Director, HEOR Strategy, Global Immunology Pipeline
Core
Leads the development and execution of integrated Health Economics and Outcomes Research (HEOR) evidence strategies for dermatology and rheumatology pipeline assets to secure label-enabling endpoints and support global access.
Role type
Director, HEOR Strategy
Builds
End-to-end holistic evidence strategies, clinical outcomes assessment plans, real-world evidence generation programs, and economic value assessments for immunology assets.
Domain
Biopharmaceuticals / Immunology / Health Economics and Outcomes Research
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
Health Economics, Outcomes Research, Market Access, Clinical Outcomes Assessment (COA), Real-World Evidence (RWE) generation, Economic Value Assessment, HTA strategy, Global regulatory landscape knowledge, Cross-functional leadership, Strategic planning
Preferred skills
Immunology therapeutic area experience, Advanced degree (PhD or PharmD/MS), Experience leading evidence generation activities, Executive presence, Cross-functional team management
Technologies
PROs/COAs, HTA dossiers, Scenario analysis tools
Responsibilities
Lead HEOR Strategy for immunology assets from proof of concept through Ph3; Drive matrix decision-making via Pipeline Commercialization Model; Lead Clinical Outcomes Assessment strategy including PRO/COA selection and regulatory engagement; Drive real-world evidence generation to inform trial design; Guide economic value assessments for pricing and reimbursement; Develop global value dossiers and HTA strategies; Shape therapeutic area disease strategies via evidence identification.
Seniority
Director, strategic leadership & cross-functional influence